Thermo Fisher Scientific Inc. closed 8.73% below its 52-week high of $627.88, which the company reached on September 10th.

Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? Thermo Fisher Scientific (TMO), which ...

Ameritas Advisory Services LLC reduced its stake in Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 19.8% during ...

The CDMO's growth strategy, capital deployment approach, and work with AI, among other things, have been key to its 2024 ...

Thermo Fisher Scientific Inc (TMO) stock saw a decline, ending the day at $559.65 which represents a decrease of $-2.06 or -0.37% from the prior close of $561.71. The stock opened at $562.46 and ...

Thermo Fisher TMO has been suffering due to a continuous decline in testing sales. Also, competitive headwinds and currency ...

Lyndra Therapeutics and Thermo Fisher Scientific have entered a strategic partnership to develop Lyndra's long-acting oral ...

Respiratory disease testing companies are Koninklijke Philips N.V., Niterra., Thermo Fisher Scientific, QIAGEN, Abbott, Danaher Corp, Siemens Healthineers, etc ...

Assenagon Asset Management S.A. cut its holdings in shares of Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 61.6% ...

As Lyndra Therapeutics works to advance long-acting oral drugs for a range of diseases, the Massachusetts-based biotech is ...

Shares of Thermo Fisher Scientific Inc. TMO rose 1.86% to $561.71 Thursday, on what proved to be an all-around rough trading ...